Thomas C. Popeck
Known title: CEO, Henry Schein ProductsCIK: 0002057014
Associated companies
Transaction History
| HSIC | ▼ Sell | Open Market | 1,355 | $99K | 3/19/2026 | View on chart |
| HSIC | ▼ Sell | Tax Withholding | 587 | $44K | 3/16/2026 | View on chart |
| HSIC | ▲ Buy | Grant | 53,206 | $0 | 3/6/2026 | View on chart |
| HSIC | ▼ Sell | Tax Withholding | 137 | $11K | 2/27/2026 | View on chart |
| HSIC | ▼ Sell | Other | 1,202 | $0 | 2/27/2026 | View on chart |
| HSIC | ▼ Sell | Other | 535 | $0 | 3/14/2025 | View on chart |
| HSIC | ▲ Buy | Grant | 14,247 | $0 | 3/10/2025 | View on chart |
| HSIC | ▼ Sell | Tax Withholding | 1,095 | $78K | 3/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Henry Schein Extends Credit Facility Amid Market Growth Projections
Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.
Henry Schein Extends Credit Facility Amid Market Growth Projections. Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.